InvestorsHub Logo
Followers 5
Posts 475
Boards Moderated 0
Alias Born 09/27/2012

Re: entdoc post# 174396

Friday, 04/25/2014 4:54:47 PM

Friday, April 25, 2014 4:54:47 PM

Post# of 346054
entdoc,

I'll take $16.00 by years end, but won't argue with $100! Three catalysts hopefully not far off that could move the needle...

1) partner

2) company announces no more dilutive financing

3) Class action suit gets tossed out (perhaps minimal, but should happen 5/5 or thereabouts.)

As far as new retail money, I don't know how many full service retail brokers are out there putting clients into PPHM. The company has been around for awhile, so I would guess that most of the buyers who like clinical stage biotech are already in.

Great weekend all!


skweze, agreed there are not a lot of buyers. Market action requires lubrication with the uninitiated and uninformed player's money, and there are painfully few fools frequenting the PPHM board. Not that there aren't a few of us trapped here wishing we were in Exxon-land or even St. John, USVI. But on the whole, those of us remaining through > a decade of holding and accumulating PPHM, are committed to not easily losing our hard-earned money. The cautious and informed optimism of this PPHM IHub blog, and of die-hard PPHM stockholders, is off-putting to the usual cannibals and criminals trying to trap unsuspecting and unwary new "players". All here are invested in PPHM, hoping to move the ball closer to the goal-line. And through PPHM science that is exactly what has, in fact, happened. Anyone here with a modicum of scientific acumen knows what a contribution PPHM and UTSW Dept. of Pharmacology has made. And Dr. Philip Thorpe from that institution and department. Absolutely outstanding examples of scientific inquiry. The missteps possible when the eyes of the scientific community are zeroed in on a new concept are many, and PPHM in my opinion, has made few mistakes. The tragedy is that if a technology isn't given away to established interests, it must overcome an incredible number of marketplace hurdles from competition. No buyers? No wonder. We aren't giving anything away here. We are not thrilled this pump and dump here, or those who clog up the communications channels with nonsense aimed at the gullible new trader. I do not personally care that the stock price remains right where it is. As long as it hits $100 by year's end. Cheers everyone. This has really been sumpin'!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News